• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hillrom beats The Street in Q4

Hillrom beats The Street in Q4

November 6, 2020 By Chris Newmarker

HillromHillrom (NYSE:HRC) today reported fourth-quarter results that exceeded the consensus forecast on Wall Street, and company officials foresee stronger-than-expected earnings in the coming months.

The Chicago-based maker of hospital beds, patient monitoring and diagnostic equipment and more reported profits of $42.4 million, or 63¢ per share, on sales of $705.3 million for the three months ended September 30, 2020, for a bottom-line gain of 52% and sales down –10% compared with Q4 2019. Revenue in Q4 2020 included $35 million from one-time COVID-related purchases.

Adjusted to exclude one-time items, earnings per share were $1.17, 10¢ ahead of The Street, where analysts were looking EPS of $1.07 on sales of $696.4 million.

“We delivered on our fiscal fourth-quarter expectations and achieved full-year adjusted earnings growth of 9%, in line with our original guidance range provided a year ago,” Hillrom CEO John Groetelaars said in a news release.

“I’m very proud of our progress in 2020 toward our vision of Advancing Connected Care, the extraordinary efforts to support peak customer demand, and steps we have taken to accelerate Hillrom’s business transformation,” Groetelaars said. “With compelling value propositions across our diverse portfolio of connected solutions, we enter fiscal 2021 with encouraging recovery trends, confidence in our future growth prospects, and an unwavering commitment to enhancing shareholder value.”

Hillrom expects revenue to drop –3% to –5% during the current quarter, as well as the full fiscal year 2021. The company during Q1 2021 projects adjusted earnings of $1.05 to $1.10 per diluted share — higher than the 96¢ per share that’s presently the consensus on The Street.

Investors reacted by sending HRC shares up more than 4% to $92.06 apiece by late morning trading today. MassDevice‘s MedTech 100 Index, which includes the stocks of the world’s largest medical device companies, is up slightly.

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Hillrom

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy